Your browser doesn't support javascript.
loading
Thyroid dysfunction with atezolizumab plus bevacizumab after lenvatinib in hepatocellular carcinoma: A case series.
Ichimura, Takenori; Ichikura, Daisuke; Hinata, Miwa; Hida, Noriko; Baba, Toshiyuki.
Afiliación
  • Ichimura T; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
  • Ichikura D; Department of Pharmacy Services, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Hinata M; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
  • Hida N; Department of Pharmacy Services, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Baba T; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
SAGE Open Med Case Rep ; 11: 2050313X231164488, 2023.
Article en En | MEDLINE | ID: mdl-37009547
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: SAGE Open Med Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: SAGE Open Med Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón